Boceprevir is a protease inhibitor and antiviral agent used for treating chronic hepatitis C virus genotype 1 infection. It functions by binding to the HCV nonstructural protein 3 active site, thereby… Read more
![Chemical structure of (3R,5aS,6aR,6bS)-6,6-Dimethyl-3-phenyltetrahydro-3H-cyclopropa[3,4]pyrrolo[1,2-c]oxazol-5(1H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F219753-99-8-3R5aS6aR6bS-66-Dimethyl-3-phenyltetrahydro-3H-cyclopropa34pyrrolo12-coxazol-51H-one.png&w=3840&q=75)
![Chemical structure of (3R,7aS)-1,7a-Dihydro-3-phenyl-3H,5H-pyrrolo[1,2-c]oxazol-5-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F134107-65-6-3R7aS-17a-Dihydro-3-phenyl-3H5H-pyrrolo12-coxazol-5-one.png&w=3840&q=75)
![Chemical structure of (3R,7aS)-Tetrahydro-3-phenyl-3H,5H-pyrrolo[1,2-c]oxazol-5-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F103201-79-2-3R7aS-Tetrahydro-3-phenyl-3H5H-pyrrolo12-coxazol-5-one.png&w=3840&q=75)













Boceprevir is a protease inhibitor and antiviral agent used for treating chronic hepatitis C virus genotype 1 infection. It functions by binding to the HCV nonstructural protein 3 active site, thereby inhibiting viral replication. This category offers a comprehensive selection of boceprevir reference standards essential for pharmaceutical laboratories conducting quality control and regulatory testing. These materials include a variety of impurities, synthetic intermediates, and degradation products critical for accurate impurity profiling and method validation. Furthermore, the inclusion of stable isotope labelled compounds provides investigators with reliable internal standards for quantitative analysis in biological matrices. These analytical tools support the precise monitoring of drug quality and stability throughout the manufacturing process, ensuring that analytical methods remain robust and compliant with industry requirements for the safety and efficacy of the parent therapeutic.